查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600296

通用感染疾病治疗市场：按疾病类型、治疗方法、给药途径和最终用户分类 - 2025-2030 年全球预测

Zoonotic Disease Treatment Market by Disease Type (Hantavirus, Leishmaniasis, Lyme Disease), Treatment (Antibiotics, Antifungal Medications, Antiparasitic Treatments), Route of Administration, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年通用感染疾病治疗市场价值为381.1亿美元，预计2024年将达到401.6亿美元，复合年增长率为5.45%，2030年将达552.7亿美元，预计将达到1000万美元。

通用感染疾病治疗市场包括动物和人类之间传播的疾病的诊断、预防和治疗。随着人类、动物和生态世界之间的连结不断增加，新冠肺炎 (COVID-19)、伊波拉出血热和兹卡等通用感染疾病凸显了有效管理的必要性。这些治疗对于保护公众健康至关重要，并在医院、诊所和研究机构中得到应用。快速的都市化、国际旅行的增加以及人类与动物接触的增加正在推动需求，将医疗保健和製药行业定位为重要的最终用途行业。

主要市场统计
基准年[2023] 381.1亿美元
预测年份 [2024] 401.6亿美元
预测年份 [2030] 552.7亿美元
复合年增长率（%） 5.45%

关键的成长要素包括诊断工具的技术进步、政府和非政府资金的增加以及对整合人类、动物和环境健康的跨学科「同一个健康」方法的更多关注。对生物技术和疫苗开发的投资不断增加，为寻求开拓创新解决方案的市场相关人员提供了潜在机会。解决抗菌素抗药性并整合人工智慧驱动的预测模型是一个有前途的研究和创新领域，为增强疾病预测和应对策略提供了商业前景。

然而，市场面临挑战，包括监管障碍、开发和部署先进治疗方法的高成本以及资源匮乏地区监测基础设施的差距。资料共用和国际政策协调的不一致也可能阻碍有效的全球应对措施的协调。为了缓解这些限制，我们建议促进官民合作关係，加强跨部门合作，并倡导建立更强大的全球卫生框架。

毕竟，随着新兴感染疾病威胁的增加，保护公众健康的迫切需求动态地驱动着市场动态。企业应专注于全面的监测系统、创新的疫苗平台和扩充性的治疗解决方案，以及灵活的供应链和区域性的生产能力。透过利用基因组学和生物资讯学的进步，公司可以适应这个复杂且不断变化的环境并取得成功。

市场动态：快速发展的通用感染疾病治疗市场的关键市场洞察

通用感染疾病治疗市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 政府针对通用感染疾病的措施和政策
    • 全球通用感染疾病增加
    • 扩大抗病毒药物和疫苗
  • 市场限制因素
    • 缺乏对通用感染疾病的认识与教育
  • 市场机会
    • 扩大兽医服务和动物保健以预防通用感染疾病
    • 加大生物技术投入，加速先进疗法研发
  • 市场挑战
    • 通用感染疾病治疗的复杂监管要求

波特的五力：驾驭通用感染疾病治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解通用感染疾病治疗市场的外在影响

外部宏观环境因素在塑造通用感染疾病治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解通用感染疾病治疗市场的竞争状况

对通用感染疾病治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV通用感染疾病市场供应商的定位矩阵绩效评估

FPNV定位矩阵是评估通用感染疾病治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，以规划通用感染疾病治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对通用感染疾病治疗市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 政府应对通用感染疾病的措施和政策
      • 全球通用感染疾病的发生率正在上升
      • 增加抗病毒药物和疫苗的使用
    • 抑制因素
      • 缺乏对通用感染疾病的认识与教育
    • 机会
      • 扩大兽医服务和动物保健以预防通用感染疾病
      • 生物技术投资的增加推动先进治疗方法的发展
    • 任务
      • 通用感染疾病治疗的复杂监管要求
  • 市场区隔分析
    • 治疗：由于急性细菌感染疾病增加，对抗生素的需求增加
    • 最终使用者：兽医医院的快速扩张，用于治疗多种通用感染疾病
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章通用感染疾病治疗市场：依疾病类型

  • 汉他病毒属
  • 利什曼原虫症
  • 莱姆病
  • 狂犬病
  • 癣
  • 弓浆虫病
  • 结核
  • 兔热病
  • 病毒性肝炎

第七章通用感染疾病治疗市场（依治疗分类）

  • 抗生素
  • 抗真菌药物
  • 驱虫治疗
  • 抗病毒药物
  • 疫苗

第八章通用感染疾病治疗市场：依给药途径分类

  • 可注射的
  • 口服
  • 话题

第九章通用感染疾病治疗市场：依最终使用者分类

  • 家庭保健
  • 兽医诊所
  • 动物医院

第十章 北美和南美通用感染疾病治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太通用感染疾病治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲通用感染疾病治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 华盛顿州立大学获得 150 万美元津贴，用于防止动物间病毒在牲畜中传播
    • 雷迪博士实验室在美国推出广效抗生素来对抗细菌感染疾病
  • 战略分析和建议

公司名单

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cadila Pharmaceuticals Limited
  • CSC Pharmaceuticals International
  • CSL Limited
  • CureVac NV
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Emergent BioSolutions Inc.
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • Gilead Sciences, Inc.
  • GSK PLC
  • Johnson & Johnson Services, Inc.
  • Kamada Ltd.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi SA
  • Sinovac Biotech Ltd.
  • Taj Pharmaceuticals Limited
  • Takeda Pharmaceutical Company Limited
  • Vaxart, Inc.
Product Code: MRR-0315DDADCE31

The Zoonotic Disease Treatment Market was valued at USD 38.11 billion in 2023, expected to reach USD 40.16 billion in 2024, and is projected to grow at a CAGR of 5.45%, to USD 55.27 billion by 2030.

The zoonotic disease treatment market involves the diagnosis, prevention, and treatment of diseases transmitted between animals and humans. As the global interface between humans, animals, and ecosystems continues to increase, zoonotic diseases such as COVID-19, Ebola, and Zika highlight the necessity for effective management. These treatments are pivotal in safeguarding public health, with applications spanning hospitals, clinics, and research institutions. Rapid urbanization, the rise of international travel, and expanding human-animal contact drive demand, positioning the healthcare and pharmaceutical industries as crucial end-use sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 38.11 billion
Estimated Year [2024] USD 40.16 billion
Forecast Year [2030] USD 55.27 billion
CAGR (%) 5.45%

Key growth factors include technological advancements in diagnostic tools, increased governmental and non-governmental funding, and a rising focus on interdisciplinary 'One Health' approaches that integrate human, animal, and environmental health. The expanding investment in biotechnology and vaccine development presents potential opportunities for market players aiming to pioneer innovative solutions. Addressing antimicrobial resistance and integrating AI-driven predictive modeling represent promising areas for research and innovation, offering prospects for businesses to enhance disease forecasting and response strategies.

However, the market faces challenges, such as regulatory hurdles, the high cost of developing and deploying advanced treatments, and gaps in surveillance infrastructures in low-resource settings. Inconsistencies in data sharing and international policy alignment can also hinder effective global response coordination. As such, fostering public-private partnerships, enhancing cross-sector collaborations, and advocating for strengthened global health frameworks are recommended to mitigate these constraints.

Ultimately, the zoonotic disease treatment market is dynamic, driven by the urgent need to protect public health amid the growing threat of emerging infectious diseases. Companies should focus on comprehensive surveillance systems, innovative vaccine platforms, and scalable therapeutic solutions, emphasizing agile supply chains and localized production capacities to effectively address regional demands. In leveraging advancements in genomics and bioinformatics, businesses can better adapt and thrive in this intricate, evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Zoonotic Disease Treatment Market

The Zoonotic Disease Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and policies addressing zoonotic diseases
    • Rising incidences of zoonotic diseases globally
    • Increasing prevalence of antiviral drugs and vaccines
  • Market Restraints
    • Limited awareness and education about zoonotic diseases
  • Market Opportunities
    • Expansion of veterinary services and animal healthcare for zoonotic disease prevention
    • Rising investment in biotechnology fostering development of advanced treatments
  • Market Challenges
    • Complex regulatory requirements for zoonotic disease treatments

Porter's Five Forces: A Strategic Tool for Navigating the Zoonotic Disease Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Zoonotic Disease Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Zoonotic Disease Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Zoonotic Disease Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Zoonotic Disease Treatment Market

A detailed market share analysis in the Zoonotic Disease Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Zoonotic Disease Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Zoonotic Disease Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Zoonotic Disease Treatment Market

A strategic analysis of the Zoonotic Disease Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Zoonotic Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bavarian Nordic A/S, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Cadila Pharmaceuticals Limited, CSC Pharmaceuticals International, CSL Limited, CureVac N.V., Dr. Reddy's Laboratories, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Genentech, Inc., Gilead Sciences, Inc., GSK PLC, Johnson & Johnson Services, Inc., Kamada Ltd., Merck & Co., Inc., Moderna, Inc., Mylan N.V., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Sinovac Biotech Ltd., Taj Pharmaceuticals Limited, Takeda Pharmaceutical Company Limited, and Vaxart, Inc..

Market Segmentation & Coverage

This research report categorizes the Zoonotic Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Hantavirus, Leishmaniasis, Lyme Disease, Rabies, Ringworm, Toxoplasmosis, Tuberculosis, Tularemia, and Viral Hepatitis.
  • Based on Treatment, market is studied across Antibiotics, Antifungal Medications, Antiparasitic Treatments, Antiviral Medications, and Vaccines.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on End-User, market is studied across Home Healthcare, Veterinary Clinics, and Veterinary Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and policies addressing zoonotic diseases
      • 5.1.1.2. Rising incidences of zoonotic diseases globally
      • 5.1.1.3. Increasing prevalence of antiviral drugs and vaccines
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and education about zoonotic diseases
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of veterinary services and animal healthcare for zoonotic disease prevention
      • 5.1.3.2. Rising investment in biotechnology fostering development of advanced treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory requirements for zoonotic disease treatments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Increased demand for antibiotics with rise in acute bacterial infections
    • 5.2.2. End-User: Rapid expansion of veterinary hospitals for treating extensive zoonotic diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Zoonotic Disease Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Hantavirus
  • 6.3. Leishmaniasis
  • 6.4. Lyme Disease
  • 6.5. Rabies
  • 6.6. Ringworm
  • 6.7. Toxoplasmosis
  • 6.8. Tuberculosis
  • 6.9. Tularemia
  • 6.10. Viral Hepatitis

7. Zoonotic Disease Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Antifungal Medications
  • 7.4. Antiparasitic Treatments
  • 7.5. Antiviral Medications
  • 7.6. Vaccines

8. Zoonotic Disease Treatment Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Zoonotic Disease Treatment Market, by End-User

  • 9.1. Introduction
  • 9.2. Home Healthcare
  • 9.3. Veterinary Clinics
  • 9.4. Veterinary Hospitals

10. Americas Zoonotic Disease Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Zoonotic Disease Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Zoonotic Disease Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. WSU Secures USD 1.5M Grant to Combat Animal-to-Human Virus Spread in Livestock
    • 13.3.2. Dr. Reddy's Laboratories Launches Broad-Spectrum Antibiotics in the U.S. to Tackle Bacterial Infections
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. Bavarian Nordic A/S
  • 3. Bayer AG
  • 4. Boehringer Ingelheim GmbH
  • 5. Bristol-Myers Squibb Company
  • 6. Cadila Pharmaceuticals Limited
  • 7. CSC Pharmaceuticals International
  • 8. CSL Limited
  • 9. CureVac N.V.
  • 10. Dr. Reddy's Laboratories
  • 11. Eli Lilly and Company
  • 12. Emergent BioSolutions Inc.
  • 13. F. Hoffmann-La Roche AG
  • 14. Genentech, Inc.
  • 15. Gilead Sciences, Inc.
  • 16. GSK PLC
  • 17. Johnson & Johnson Services, Inc.
  • 18. Kamada Ltd.
  • 19. Merck & Co., Inc.
  • 20. Moderna, Inc.
  • 21. Mylan N.V.
  • 22. Novartis AG
  • 23. Pfizer Inc.
  • 24. Regeneron Pharmaceuticals, Inc.
  • 25. Sanofi S.A.
  • 26. Sinovac Biotech Ltd.
  • 27. Taj Pharmaceuticals Limited
  • 28. Takeda Pharmaceutical Company Limited
  • 29. Vaxart, Inc.

LIST OF FIGURES

  • FIGURE 1. ZOONOTIC DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ZOONOTIC DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ZOONOTIC DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ZOONOTIC DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ZOONOTIC DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ZOONOTIC DISEASE TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY HANTAVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY LYME DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RINGWORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TOXOPLASMOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TULAREMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VIRAL HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIFUNGAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIPARASITIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIVIRAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. ZOONOTIC DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 200. ZOONOTIC DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023